TY - JOUR
T1 - Kinin B2 receptor localization and expression in the hypothalamo-pituitary-adrenal axis of spontaneously hypertensive rats
AU - Qadri, Fatimunnisa
AU - Schwartz, Eike C.
AU - Häuser, Walter
AU - Jöhren, Olaf
AU - Müller-Esterl, Werner
AU - Dominiak, Peter
PY - 2003/1/1
Y1 - 2003/1/1
N2 - Objective: An enhanced hypothalamo-pituitary-adrenocortical (HPA) activity has been demonstrated during onset of high blood pressure in spontaneously hypertensive rats (SHR). Furthermore, compared to normotensive Wistar-Kyoto (WKY) rats, SHR show hypersensitivity to bradykinin (BK)-induced pressor responses which may be caused by an upregulation of B2 receptor expression in the brain. Methods: We performed an immuohistochemical localization and measured gene expression of B2 receptors in the hypothalamus, pituitary and adrenal glands of SHR at three ages corresponding to the development of hypertension, i.e. prehypertensive phase, onset of hypertension and established hypertension. Using reverse transcriptase polymerase chain reaction (RT-PCR) and Western blot technique, B2 receptor mRNA and protein levels, respectively, were measured. Results: A specific immunostaining for B2 receptors was observed in the hypothalamic nuclei paraventricularis (PVN) and supraopticus (SON). In the pituitary and adrenal glands, a strong immunostaining was observed in neurohypophysis (NH) and adrenal medulla, respectively. At all ages tested, B2 receptor mRNA and protein levels were higher in the hypothalamus and adrenal glands of SHR compared to age-matched WKY rats. Among SHR, the mRNA level was increased in neurohypophysis with age, and no difference was found in the adenohypophysis (AH) between SHR and WKY rats. Conclusion: The data demonstrate a specific localization and an upregulation of B2 receptor expression in the hypothalamus and adrenal glands of SHR, providing an anatomical and molecular basis for a possible contributory role to bradykinin-induced hypersensitivity of cardiovascular responses. The increased B2 receptor expression in the hypothalamus and adrenal glands may also play a role in the abnormalities of the HPA axis in SHR during the development of hypertension.
AB - Objective: An enhanced hypothalamo-pituitary-adrenocortical (HPA) activity has been demonstrated during onset of high blood pressure in spontaneously hypertensive rats (SHR). Furthermore, compared to normotensive Wistar-Kyoto (WKY) rats, SHR show hypersensitivity to bradykinin (BK)-induced pressor responses which may be caused by an upregulation of B2 receptor expression in the brain. Methods: We performed an immuohistochemical localization and measured gene expression of B2 receptors in the hypothalamus, pituitary and adrenal glands of SHR at three ages corresponding to the development of hypertension, i.e. prehypertensive phase, onset of hypertension and established hypertension. Using reverse transcriptase polymerase chain reaction (RT-PCR) and Western blot technique, B2 receptor mRNA and protein levels, respectively, were measured. Results: A specific immunostaining for B2 receptors was observed in the hypothalamic nuclei paraventricularis (PVN) and supraopticus (SON). In the pituitary and adrenal glands, a strong immunostaining was observed in neurohypophysis (NH) and adrenal medulla, respectively. At all ages tested, B2 receptor mRNA and protein levels were higher in the hypothalamus and adrenal glands of SHR compared to age-matched WKY rats. Among SHR, the mRNA level was increased in neurohypophysis with age, and no difference was found in the adenohypophysis (AH) between SHR and WKY rats. Conclusion: The data demonstrate a specific localization and an upregulation of B2 receptor expression in the hypothalamus and adrenal glands of SHR, providing an anatomical and molecular basis for a possible contributory role to bradykinin-induced hypersensitivity of cardiovascular responses. The increased B2 receptor expression in the hypothalamus and adrenal glands may also play a role in the abnormalities of the HPA axis in SHR during the development of hypertension.
UR - http://www.scopus.com/inward/record.url?scp=0037333344&partnerID=8YFLogxK
U2 - 10.1016/S1567-5769(02)00269-2
DO - 10.1016/S1567-5769(02)00269-2
M3 - Journal articles
C2 - 12639805
AN - SCOPUS:0037333344
SN - 1567-5769
VL - 3
SP - 285
EP - 292
JO - International Immunopharmacology
JF - International Immunopharmacology
IS - 3
ER -